What research protocols are currently available for women at risk for preterm birth?
The Utah Preterm Birth Prevention Clinic represents cooperation between the University of Utah and Intermountain Health Care. Both the University of Utah and Intermountain Health Care have a long history of participation in clinical trials that have made landmark discoveries regarding preterm birth. The physicians that manage and direct the Utah Preterm Birth Prevention Clinic also participate in multi-center trials that are designed and funded by the National Institute of Health. These include the Maternal-Fetal Medicine Units Network trials as well as a trial designed by the Genomic and Proteomic etwork for Preterm Birth Research. While you are evaluated in the Utah Preterm Birth Prevention Clinic, you will be offered the chance to participate in cutting edge research designed to identify the causes of preterm birth and the optimal management of patients who are at risk.
- Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?
- What women are eligible for 17P treatment to reduce the risk of preterm birth recurrence?
- Does midtrimester cervical length ≥25 mm predict preterm birth in high-risk women?